The Naloxone Market size is expected to grow at an annual average of 2% during 2021-2027. Naloxone is an opioid antagonist used to treat opioid overdose. Opioids are analgesics used to treat chronic pain, but their non-medical use is rapidly increasing. Opioid abuse is increasing worldwide as opioids induce euphoria along with pain-relieving effects. According to the National Institute on Drug Abuse, about 130 people die every day in the United States alone from opioid abuse.
(Get 15% Discount on Buying this Report)
A full report of Naloxone Market is available at: https://www.orionmarketreports.com/naloxone-market/38279/
The following segmentation are covered in this report:
By Type
- Spray Forms
- Injectable Forms
By Application
- Drug Store
- Hospital Pharmacies
- Online
Company Profile
- ADAPT Pharma
- Amphastar Pharmaceuticals
- Pfizer
- Kaleo
- Sandoz
- Amneal Pharmaceuticals
- West Ward Pharmaceuticals
- Mylan
The report covers the following objectives:
- Proliferation and maturation of trade in the global Naloxone Market
- The market share of the global Naloxone Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Naloxone Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Naloxone Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
